EOSC4Cancer will make diverse types of cancer data accessible: genomics, imaging, medical, clinical, environmental and socio-economic. It will use and enhance federated and interoperable systems for securely identifying, sharing, processing and reusing FAIR data across borders and offer them via community-driven analysis environments. Cancer’s complex nature requires integration of advanced research data across national boundaries to enable progress. The Horizon Europe mission board for cancer has identified access to data, knowledge, and digital services – accessible across the European Research Area through federated infrastructures – as a key enabling condition for success. The better we organise cancer data across Europe, the better and faster we can bring the fruits of new biological and technical innovations to the benefit of EU citizens/patients. EOSC4Cancer’s well curated data sets will be essential input for reproducible and robust analytics and computational methods – including machine learning and artificial intelligence. EOSC4Cancer’s five use cases will cover the patient journey from cancer prevention over diagnosis to treatment, laying the foundation of data trajectories and workflows for future European Cancer Mission projects. EOSC4Cancer brings together a consortium of 29 organisations from 13 countries, including cancer research centres, research infrastructures, leading research groups, hospitals, and supercomputing centres. To make the developments sustainable, EOSC4Cancer will leverage the partners’ research infrastructures partners and the EOSC ecosystem. It will also serve the European Cancer Mission, by engaging with large international coalitions (e.g., ICGC-Argo, GA4GH, 1+MG/B1MG, Cancer Core Europe, European Cancer Information System, European Network of Cancer Registries, Innovative Partnership for Action Against Cancer Joint Action) and patients/survivors associations.
Network detailsCatalogueACBB
Augsburg Central BioBank
Description
The Augsburg Central BioBank is a centralized biobank at the University Hospital of Augsburg. It is divided into two parts, consisting of liquid and solid biosamples. For solid biosamples, we collect oncological biosamples with the main focus on lung, mammary and colorectal carcinomas with the respective metastases and rare tumors, which include pediatric cases. Moreover, the biobank offers services for sample collection with a specific research focus. The liquid part of the biobank includes non-solid samples (blood, urine etc.) and clinical data from oncological patients.
General Design
- Type
- Biobank
- Start/End data collection
- not available
- PID
- 21.12110/1.35F0-0884-D678
- External identifiers
- bbmri-eric:ID:DE_ACBB
Population
- Countries
- Germany
Contributors
Subpopulations
List of subpopulations for this resource
| Name | Description | Number of participants | |
|---|---|---|---|
No results for current selection |
Networks
Part of networks